Merck
CN
  • Fatalities involving acetaminophen combination products reported to United States poison centers.

Fatalities involving acetaminophen combination products reported to United States poison centers.

Clinical toxicology (Philadelphia, Pa.) (2013-10-18)
Suzanne Doyon, Wendy Klein-Schwartz, Samantha Lee, Michael C Beuhler
ABSTRACT

Deaths from overdose of acetaminophen (APAP) combination medications are reported, yet the individual ingredients are not well examined as individual putative causes of death. To examine the individual contribution of APAP or other ingredient(s) to fatalities resulting from ingestion of APAP combination products reported to poison centers. A search in the United States (US) National Poison Data System between 1 January 2000 and 31 December 2009 (10 years) was conducted. Only fatal cases determined by American Association of Poison Control Centers Fatality Review team to be caused by ingestion of one or more APAP combination products were included. The fatality abstract narrative for each case was obtained. Each narrative abstract was rated independently by four reviewers and putative cause of death was determined to be APAP, 'other ingredient' or 'unable to determine'. Fleiss' Kappa test was utilized to assess interrater agreement. Three hundred and thirty-seven deaths met inclusion criteria: 204 were due to suicides, 96 were the result of nonmedical use, 3 were from a therapeutic error, 1 resulted from an unsupervised pediatric ingestion, and 33 were due to unknown reason for exposure. The overall putative cause of death was APAP in 60.8%, other ingredients in 29.7%, and unable to determine in 9.5% of fatalities. APAP was responsible for the fatality in 79.2% of deaths resulting from nonmedical use of APAP combination products. Fleiss Kappa was 0.74, indicating substantial interrater agreement. The most common putative cause of death in fatal overdoses involving APAP combination products reported to US poison centers is the APAP component.

MATERIALS
Product Number
Brand
Product Description

Supelco
Diphenhydramine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Diphenhydramine hydrochloride, ≥98% (HPLC)
Supelco
Dextromethorphan HBr, certified reference material, pharmaceutical secondary standard
Supelco
Diphenhydramine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Diphenhydramine hydrochloride, European Pharmacopoeia (EP) Reference Standard